TAK ALG-12.5 (Alogliptin benzoate 12.5 mg)
Pill imprint TAK ALG-12.5 has been identified as Alogliptin benzoate 12.5 mg.
Alogliptin is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Alogliptin 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about alogliptin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 3 Reviews – Add your own review/rating
- Drug class: dipeptidyl peptidase 4 inhibitors
Other brands: Nesina
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.